PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

Mortensen Hr; Populaire P; Hoffmann L; Moeller Ds; Appelt A; Nafteux P; Muijs Ct; Grau C; Hawkins Ma; Troost Egc; Defraene G; Canters R; Clarke Cs; Weber Dc; Korevaar Ew; Haustermans K; Nordsmark M; PROTECT consortium; Gloria Vilches Freixas

doi:10.1016/j.radonc.2023.109980

PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

Mortensen Hr^*, Populaire P, Hoffmann L, Moeller Ds, Appelt A, Nafteux P, Muijs Ct, Grau C, Hawkins Ma, Troost Egc, Defraene G, Canters R, Clarke Cs, Weber Dc, Korevaar Ew, Haustermans K, Nordsmark M, PROTECT consortium, Gloria Vilches Freixas

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	109980
Number of pages	3
Journal	Radiotherapy and Oncology
Volume	190
Issue number	1
DOIs	https://doi.org/10.1016/j.radonc.2023.109980
Publication status	Published - Jan 2024

Access to Document

10.1016/j.radonc.2023.109980

Cite this

Hr, M., P, P., L, H., Ds, M., A, A., P, N., Ct, M., C, G., Ma, H., Egc, T., G, D., R, C., Cs, C., Dc, W., Ew, K., K, H., M, N., PROTECT consortium, & Vilches Freixas, G. (2024). PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. Radiotherapy and Oncology, 190(1), Article 109980. https://doi.org/10.1016/j.radonc.2023.109980

@article{fa723d2c884946a2bba1d0ae7318e597,

title = "PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer",

author = "Mortensen Hr and Populaire P and Hoffmann L and Moeller Ds and Appelt A and Nafteux P and Muijs Ct and Grau C and Hawkins Ma and Troost Egc and Defraene G and Canters R and Clarke Cs and Weber Dc and Korevaar Ew and Haustermans K and Nordsmark M and {PROTECT consortium} and {Vilches Freixas}, Gloria",

year = "2024",

month = jan,

doi = "10.1016/j.radonc.2023.109980",

language = "English",

volume = "190",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

Hr, M, P, P, L, H, Ds, M, A, A, P, N, Ct, M, C, G, Ma, H, Egc, T, G, D, R, C, Cs, C, Dc, W, Ew, K, K, H, M, N, PROTECT consortium & Vilches Freixas, G 2024, 'PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer', Radiotherapy and Oncology, vol. 190, no. 1, 109980. https://doi.org/10.1016/j.radonc.2023.109980

PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. / Hr, Mortensen; P, Populaire; L, Hoffmann et al.
In: Radiotherapy and Oncology, Vol. 190, No. 1, 109980, 01.2024.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648

T2 - A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

AU - Hr, Mortensen

AU - P, Populaire

AU - L, Hoffmann

AU - Ds, Moeller

AU - A, Appelt

AU - P, Nafteux

AU - Ct, Muijs

AU - C, Grau

AU - Ma, Hawkins

AU - Egc, Troost

AU - G, Defraene

AU - R, Canters

AU - Cs, Clarke

AU - Dc, Weber

AU - Ew, Korevaar

AU - K, Haustermans

AU - M, Nordsmark

AU - PROTECT consortium

AU - Vilches Freixas, Gloria

PY - 2024/1

Y1 - 2024/1

U2 - 10.1016/j.radonc.2023.109980

DO - 10.1016/j.radonc.2023.109980

M3 - Article

SN - 0167-8140

VL - 190

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - 1

M1 - 109980

ER -

Hr M, P P, L H, Ds M, A A, P N et al. PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. Radiotherapy and Oncology. 2024 Jan;190(1):109980. doi: 10.1016/j.radonc.2023.109980